Trillium Therapeutics Virtual R&D Day

Trillium's inaugural R&D Day was held on Wednesday, April 28, 2021 from 10:00 am to 1:00 pm ET.

The virtual event included a clinical update for TTI-622 and TTI-621, Trillium's new strategic priorities in terms of target indications and drug combinations across hematologic malignancies and solid tumors, and updated milestones and guidance for 2021. 

A replay of the R&D Day webcast can be found here.  

Trillium R&D Day Presentation